Evoke Pharma Inc

EVOK12 Dec 2024
Healthcare
$4.2
+0.00 (+0.49%)
Lowest Today
$4.07
Highest Today
$4.2
Today’s Open
$4.2
Prev. Close
$4.08
52 Week High
$15.13
52 Week Low
$3.54
To Invest in Evoke Pharma Inc

Evoke Pharma Inc

Healthcare
EVOK12 Dec 2024
+0.00 (+0.49%)
1M
3M
6M
1Y
5Y
Low
$4.07
Day’s Range
High
$4.2
4.07
52 Week Low
$3.54
52-Week Range
52 Week High
$15.13
3.54
1 Day
-
1 Week
-1.92%
1 month return
-25.68%
3 month return
-2.62%
6 month return
+763.3%
1 Year return
+242.85%
3 Years return
-45.24%
5 Years return
-79.33%
10 Years return
-
Institutional Holdings
AIGH Capital Management, LLC
4.75
Bleichroeder LP
4.63
Nantahala Capital Management, LLC
3.79
Corsair Capital Management LLC
0.79
Vanguard Institutional Extnd Mkt Idx Tr
0.17
Fidelity Extended Market Index
0.16
Fidelity Series Total Market Index
0.1

Market Status

Fundamentals
Market Cap
6.35 mln
PB Ratio
1.4
PE Ratio
0
Enterprise Value
-0.19 mln
Total Assets
7.07 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.
Organisation
Evoke Pharma Inc
Employees
4
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Matthew J. D'Onofrio MBA
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step